Disease Latency according to Asbestos Exposure Characteristics among Malignant Mesothelioma and Asbestos-Related Lung Cancer Cases in South Korea

Int J Environ Res Public Health. 2022 Nov 29;19(23):15934. doi: 10.3390/ijerph192315934.

Abstract

Korea was one of the major consumers of asbestos in the late 1900s, and asbestos-related disease patients have been reported continuously to date, owing to long disease latency. Several studies have been conducted to predict the future incidence of malignant mesothelioma and lung cancer in Korea, but little is understood about the latency time. Therefore, the aim of this study is to estimate the latency period of malignant mesothelioma and asbestos-related lung cancer in Korea and its determinants. We obtained information from the Environmental Health Centers for Asbestos in Korea on the history of asbestos exposure and demographic characteristics of 1933 patients with malignant mesothelioma and asbestos-related lung cancer. In our study, the latency periods for malignant mesothelioma and lung cancer were 33.7 and 40.1 years, respectively. Regardless of the disease type, those with a history of exposure related to the production of asbestos-containing products or asbestos factories had the shortest latency period. In addition, we observed that those who worked in or lived near asbestos mines tended to have a relatively long disease latency. Smoking was associated with shorter latency, but no linear relationship between the lifetime smoking amount (expressed in pack years) and latent time was observed. In addition, the age of initial exposure showed a negative linear association with the latency period for mesothelioma and lung cancer.

Keywords: asbestos; latency period; lung cancer; malignant mesothelioma.

MeSH terms

  • Asbestos* / toxicity
  • Humans
  • Lung Neoplasms* / chemically induced
  • Lung Neoplasms* / epidemiology
  • Mesothelioma* / epidemiology
  • Mesothelioma* / etiology
  • Mesothelioma, Malignant*
  • Occupational Exposure*
  • Republic of Korea / epidemiology

Substances

  • Asbestos

Grants and funding

This research received no external funding.